Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey

OBJECTIVES: Airway mucus obstruction is a major challenge in children admitted to the paediatric intensive care unit (PICU). We aimed to evaluate the evidence and contemporary use of the mucolytic medication dornase alfa for non-cystic fibrosis conditions in the PICU. METHODS: (1) We performed a sys...

Descripción completa

Detalles Bibliográficos
Autores principales: den Hollander, Bibiche, Linssen, Rosalie S N, Cortjens, Bart, van Etten-Jamaludin, Fardi S, van Woensel, Job B M, Bem, Reinout A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047925/
https://www.ncbi.nlm.nih.gov/pubmed/33122405
http://dx.doi.org/10.1136/ejhpharm-2020-002507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047925/
https://www.ncbi.nlm.nih.gov/pubmed/33122405
http://dx.doi.org/10.1136/ejhpharm-2020-002507

Ejemplares similares